By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ValiRx today announced its wholly owned subsidiary ValiFinn has bought the biomarkers business of Pharmatest Services for €75,000 ($96,000) plus stock.

The purchase includes five patent families and patent applications and related intellectual property. Pharmatest, based in Finland, also received 15 million shares of ValiRx stock at a price of .52 pence per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.